ArticleFrontiers in pediatrics2026
Heroes in motion - a six-year quality report and patient evaluation of a real-world exercise therapy program in pediatric oncology.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rising survival rates in pediatric oncology underscore the importance of interventions that support short- and long-term bio-psycho-social health. Exercise therapy is now recognized as a key component of tertiary prevention and provides survival benefits. In 2020, the "Heroes in Motion" (HIM) program was established at the Department of Pediatric Hematology and Oncology in Freiburg to provide exercise interventions for patients and their families. This real-world service-based evaluation summarizes six years of program implementation, monitoring, and quality improvement, including patient- and parent-reported satisfaction data. Methods: This multi-method evaluation integrates (a) quantitative data on exercise therapy details combined with structured program documentation and continuous process monitoring (2020-2025) and (b) findings from two satisfaction surveys conducted in 2020 and 2025. Results: A total of 457 patients (age range: 1-24 years) participated in the HIM program over six years. During the evaluation period, 3.860 inpatient and 813 outpatient sessions were completed. Participation covered diverse diagnoses, with increasing family involvement following the introduction of the family-centered outpatient exercise program in 2023. Satisfaction remained consistently high, with 74% ( Discussion: The HIM program proved feasible, safe, and well accepted in a real-world pediatric oncology setting. Ongoing structural development and increasing family involvement emphasize the relevance of exercise therapy within supportive care. Future efforts will focus on establishing a multimodal, family-centered program as part of routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.